AIC
HSTO

Ameritas Investment Company’s Histogen Inc. Common Stock HSTO Stock Holding History

Ameritas Investment Company’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-50
Closed -$3K – 1744
2020
Q1 		$3K Buy
+50
New +$3.9K ﹤0.01% 1532
2019
Q1 		– Sell
-7
Closed -$2K – 1917
2018
Q4 		$2K Buy
+7
New +$5.44K ﹤0.01% 1386

Other funds holding HSTO

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
IIA
IPG Investment Advisors San Diego, California $582M AUM 33.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Ameritas Investment Company's HSTO Position: Q2 2020 in Review

Ameritas Investment Company sold out of Histogen Inc. Common Stock (HSTO) in Q2 2020, closing a stake of 50 shares — an estimated $3K sold.

Ameritas Investment Company first reported a position in HSTO in Q4 2018 and held it in 2 quarters. The position peaked at $3K in Q1 2020. 19 funds tracked by Wall St. Rank hold HSTO as of Q2 2020.

  • Ameritas Investment Company reported no remaining Histogen Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Ameritas Investment Company sold 50 Histogen Inc. Common Stock shares in Q2 2020, an estimated $3K.
  • Ameritas Investment Company first reported a position in Histogen Inc. Common Stock in Q4 2018 and held it in 2 quarters.
  • Ameritas Investment Company's Histogen Inc. Common Stock position peaked at $3K in Q1 2020.
  • 19 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2020.

Based on Ameritas Investment Company's 13F filing for Q2 2020, filed 14 Aug 2020.